Frequency of adverse events with incidence ≥4% in any treatment group (treated set).
收藏NIAID Data Ecosystem2026-03-08 收录
数据链接：
官方服务：
资源简介：
aPatients were randomised 2:2:1 to the tiotropium Respimat 5 μg, tiotropium Respimat 2.5 μg and placebo Respimat groups, respectively. bThe preferred term ‘asthma’ summarises several lowest level terms. Frequency of adverse events with incidence ≥4% in any treatment group (treated set).
创建时间：
2015-12-03
